SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Genesis MedTech Group announced today that the Food and Drug Administration (FDA) has approved the Chocolate Touch® Drug-coated Balloon PTA Catheter, developed ...
WASHINGTON, DC—In PAD patients, treatment with a second-generation paclitaxel drug-coated balloon (DCB) led to better target vessel patency and less repeat revascularization in a head-to-head ...
Patients treated for a blocked artery in the leg were significantly more likely to have an open artery without further interventions at 12 months if they received the second-generation ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — A new study supports the safety and effectiveness of the Chocolate Touch drug-coated balloon for ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a showdown of ...
The drug-coated balloon (DCB) for peripheral interventions had its share of troubles in recent years before making a comeback, with the field of available devices perhaps even poised for expansion. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results